Hutchinson Lands as CEO for Start-up Prematics


Loading...

By Neil Versel

Feb. 12, 2008 | Less than two weeks after stepping down as chief executive of SureScripts, Kevin Hutchinson has landed as president and CEO of ePrescribing start-up Prematics (Bethesda, Md.), where he will attempt to jump-start physician adoption of the technology.

With Hutchinson still at the helm, SureScripts forecast ePrescribing volume to triple in 2008, but even that would account for just 7 percent of eligible scripts in the U.S. (See “Hutchinson to Step Down as SureScripts Top Exec.”) Hutchinson left SureScripts at the end of January, though he retains his seats on the American Health Information Community and the board of the eHealth Initiative.

“We just haven’t seen a model that worked well in automating the physician side,” Hutchinson tells Digital HealthCare & Productivity. He says this is true not only for himself but for Prematics chairman James Bradley, the founding CEO of another e-prescribing connectivity company, RxHub.

SureScripts is an eRx connectivity network with pharmacy roots, while RxHub is a joint venture of the nation’s largest pharmacy benefit management companies that helps users check patient eligibility at the point of care. Prematics, on the other hand, bills itself as an ePrescribing service provider for physicians, offering servers, Internet access, printers, and handheld devices, in addition to software.

“This has to be delivered as a service, not as a software product,” Hutchinson insists. “The service actually monitors the physician’s technology infrastructure. If there’s a problem with a Wi-Fi access point, we know. If there’s a problem with a printer, we know,” he adds.

Hutchinson, who starts his new job next week, says the Prematics ScriptTone service is connected to both the RxHub and SureScripts networks. “Someone has to be that last mile to these physician practices.”

The privately held company’s business model is to partner with health plans in specific geographic locations to offer ePrescribing at no cost to doctors. Prematics’ first customer is Capital BlueCross in Central Pennsylvania, which Hutchinson says has identified as many as 2,000 physicians to participate in the initial roll-out, which began last summer.

He says Prematics will announce additional deals in the coming months.

 

 

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

sas_f0910
Rethinking Clinical Trials Data Integration
Sponsored by SAS

There is a gap between the need for data integration and fully integrated systems. To find out why, SAS and Pharmaceutical Executive conducted confidential telephone interviews with senior pharmaceutical executives and CROs. This article discusses recommendations on how to achieve optimal clinical data integration, based on those interviews.



ClearTrial_BriefingOn
eClinical Trial Technologies Revolutionizing Clinical Development Efficiency
Sponsored by ClearTrial
This Bio-IT World BriefingON report, sponsored by ClearTrial, presents a selection of recent stories from Bio•IT World and sister publication, eCliniqua, that illustrate how new technologies and approaches can have a profound impact on the management and execution of clinical trials.


oracle_RDC
Remote Data Capture:Acquisition and Analysis
Sponsored by Oracle

See why Electronic Data Capture (EDC) is gaining traction in the pharmaceutical
clinical trials arena. Today approximately half of all clinical trials are conducted
electronically, and the figure is rapidly rising. Report includes contributions from
Oracle Health Sciences, Pfizer, PPD, and C3i.

 



Life Science Webcasts & Podcasts

Bio-IT World & CHI

Impact of the 1000 Genomes Project on the Next Wave of Pharmacogenomic Discovery
1000genomeInterview with M. Eileen Dolan, Ph.D., Professor, Medicine, University of Chicago and Speaker at Next-Generation Sequencing Data Management, September 27-29, 2010, Providence, RI  

The 1000 Genomes Project aims to provide detailed genetic variation data on >1000 genomes from worldwide populations using the next-generation sequencing technologies. Some of the samples utilized for the 1000 Genomes Project are the International Hap-Map samples that are composed of lymphoblastoid cell lines (LCLs) derived from individuals of different world populations. The detailed map of human genetic variation promised by the 1000 Genomes project will allow a more in-depth analysis of the contribution of genetic variation to drug response. Future studies utilizing this new resource can greatly enhance our understanding of the genetic basis of drug response and other complex traits.


Download Now 



More Podcasts

Job Openings

mskc logo
Software Engineer – Computational Biology Center

Memorial Sloan-Kettering Cancer Center seeks an Engineer to design and develop complex data analysis systems in support of cancer genomics research projects at the Computational Biology Center. Qualified candidate will have a BA, 5+ years of software development experience and expert knowledge of Java, SQL, and HTML.

Apply: www.mskcciscareers.org.  Equal opportunity and affirmative action employer.




Loading...

For reprints and/or copyright permission, please contact The YGS Group, 3650 West Market Street, York, PA;

(717) 505-9701 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.